Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, Turkey, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a fish oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are calcium collagen complexes that support joint and bone health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was founded in 2000 and is headquartered in Ålesund, Norway.
Frequently asked questions
What sector does Hofseth BioCare ASA (HBQ) operate in?
Hofseth BioCare ASA belongs to the Healthcare sector and operates in the Packaged Foods industry.
What is Hofseth BioCare ASA (HBQ) current stock price?
As of the latest data, Hofseth BioCare ASA stock price is €0.10, with a previous close of €0.10.
What is Hofseth BioCare ASA (HBQ) current market capitalization?
Hofseth BioCare ASA market cap is approximately 52.14 million.
What is Hofseth BioCare ASA (HBQ) Earnings Per Share (EPS)?
The trailing EPS is -€0.03.
What is Hofseth BioCare ASA (HBQ) EBITDA?
Hofseth BioCare ASA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -471.51 thousand.
Does Hofseth BioCare ASA (HBQ) pay dividends?
No. Hofseth BioCare ASA does not pay a dividend.
What is Hofseth BioCare ASA (HBQ) beta (volatility) score?
Hofseth BioCare ASA has a beta of 0.248, indicating lower volatility than the overall market.